Monash University, Australia’s largest university and one of the world’s top 50 research institutions, has announced the launch of the Monash Boston Hub, a new strategic base designed to strengthen the university’s collaborations with North American and European biotechnology and…
55 North, the world’s largest dedicated quantum technology venture capital fund, has announced the first close of its €300 million Fund I at €134 million, marking a significant milestone for both the European and global quantum ecosystems. The fund establishes…
Genialis, the RNA biomarker company, announced a new collaboration with Cleveland Clinic, one of the world’s leading academic medical centers, to co-develop AI-driven tools that aim to personalize treatment for patients with pancreatic ductal adenocarcinoma (PDAC)—the most prevalent and deadliest…
Thermo Fisher Scientific and AstraZeneca BioVentureHub Announce Strategic R&D Partnership to Advance Life Science Innovation. The PPD™ clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new research and development (R&D) partnership…
PINC Technologies, a Caltech spinout developing advanced integrated nonlinear photonic devices and circuits, announced the close of its Seed+ financing round, bringing total funds raised to date to $6.8 million. The funding marks a major milestone for the young company…
CytoAgents, Inc., a clinical-stage biotechnology company focused on developing safe and effective preventative therapies for life-threatening immune-related toxicities, today announced it has been awarded a $2.25 million grant from the National Institutes of Health (NIH). This grant, issued through the…
Predicta Biosciences, a precision oncology company pioneering next-generation diagnostic and therapeutic discovery solutions, today announced the successful close of a $23.4 million oversubscribed Series A financing round. The investment was led by Engine Ventures, with strong participation from Illumina Ventures,…